Simvastatin in Waldenstrom's Macroglobulinemia

Clinical trial NCT00575965 · TERMINATED

Trial details

NCT number: NCT00575965
Sponsor: Dana-Farber Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenstrom's Macroglobulinemia

Start date: 2007-11-01
Primary completion: 2011-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.